← All customer stories
Case study
Breast-health medtech
£100k landed weeks before the round.
Medtech · Innovate UK Biomedical Catalyst · July 2026
£100k
equity-free, zero match funding. Institutional de-risking at exactly the right time.
Return
34x
what they paid Ailsa over six months
Match funding
£0
required. All of it stays in the company
Score
80s
assessor score band, the level Innovate UK funds
What could you win?
Book a call